| Biodistribution of 89Zr‐trastuzumab and PET Imaging of HER2‐Positive Lesions in Patients With Metastatic Breast Cancer EC Dijkers, TH Oude Munnink, JG Kosterink, AH Brouwers, PL Jager, ... Clinical Pharmacology & Therapeutics 87 (5), 586-592, 2010 | 966 | 2010 |
| Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents RJM Brüggemann, JWC Alffenaar, NMA Blijlevens, EM Billaud, ... Clinical Infectious Diseases 48 (10), 1441-1458, 2009 | 550 | 2009 |
| Indium-111–labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer PJ Perik, MN Lub-De Hooge, JA Gietema, WTA van der Graaf, ... Journal of clinical oncology 24 (15), 2276-2282, 2006 | 458 | 2006 |
| Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging ECF Dijkers, JGW Kosterink, AP Rademaker, LR Perk, ... Journal of nuclear medicine 50 (6), 974-981, 2009 | 432 | 2009 |
| Preclinical characterisation of 111In‐DTPA‐trastuzumab MN Lub‐de Hooge, JGW Kosterink, PJ Perik, H Nijnuis, L Tran, J Bart, ... British journal of pharmacology 143 (1), 99-106, 2004 | 303 | 2004 |
| Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies AGTT Van Scheltinga, GM van Dam, WB Nagengast, V Ntziachristos, ... Journal of Nuclear Medicine 52 (11), 1778-1785, 2011 | 266 | 2011 |
| Applications of stable isotopes in clinical pharmacology RCA Schellekens, F Stellaard, HJ Woerdenbag, HW Frijlink, ... British journal of clinical pharmacology 72 (6), 879-897, 2011 | 175 | 2011 |
| The influence that electronic prescribing has on medication errors and preventable adverse drug events: an interrupted time-series study JE Van Doormaal, PMLA van den Bemt, RJ Zaal, ACG Egberts, ... Journal of the American Medical Informatics Association 16 (6), 816-825, 2009 | 174 | 2009 |
| Gastrointestinal pH and transit time profiling in healthy volunteers using the IntelliCap system confirms ileo-colonic release of ColoPulse tablets JM Maurer, RCA Schellekens, HM Van Rieke, C Wanke, V Iordanov, ... PloS one 10 (7), e0129076, 2015 | 169 | 2015 |
| Voriconazole metabolism is influenced by severe inflammation: a prospective study A Veringa, M Ter Avest, LFR Span, ER van den Heuvel, DJ Touw, ... Journal of Antimicrobial Chemotherapy 72 (1), 261-267, 2016 | 164 | 2016 |
| The role of fluoroquinolones in the treatment of tuberculosis in 2019 AD Pranger, TS Van Der Werf, JGW Kosterink, JWC Alffenaar Drugs 79 (2), 161, 2019 | 130 | 2019 |
| Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience AD Pranger, R Van Altena, RE Aarnoutse, D Van Soolingen, DRA Uges, ... European Respiratory Journal 38 (4), 888-894, 2011 | 129 | 2011 |
| Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC/MS/MS JWC Alffenaar, AMA Wessels, K Van Hateren, B Greijdanus, ... Journal of Chromatography B 878 (1), 39-44, 2010 | 127 | 2010 |
| Inflammation is associated with voriconazole trough concentrations MJP van Wanrooy, LFR Span, MGG Rodgers, ER van den Heuvel, ... Antimicrobial agents and chemotherapy 58 (12), 7098-7101, 2014 | 122 | 2014 |
| Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings RCA Schellekens, F Stellaard, D Mitrovic, FE Stuurman, JGW Kosterink, ... Journal of controlled release 132 (2), 91-98, 2008 | 119 | 2008 |
| local tumor necrosis factor-α inhibition in inflammatory bowel disease B Gareb, AT Otten, HW Frijlink, G Dijkstra, JGW Kosterink Pharmaceutics 12 (6), 539, 2020 | 117 | 2020 |
| Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients MS Bolhuis, R van Altena, D van Soolingen, WCM de Lange, DRA Uges, ... European Respiratory Journal 42 (6), 1614-1621, 2013 | 111 | 2013 |
| Medication errors: the impact of prescribing and transcribing errors on preventable harm in hospitalised patients JE Van Doormaal, PMLA van den Bemt, PGM Mol, RJ Zaal, ACG Egberts, ... BMJ Quality & Safety 18 (1), 22-27, 2009 | 107 | 2009 |
| Renal handling of technetium-99m DMSA: evidence for glomerular filtration and peritubular uptake. MJ de Lange, DA Piers, JG Kosterink, WH Van Luijk, S Meijer, ... Journal of nuclear medicine: official publication, Society of Nuclear …, 1989 | 106 | 1989 |
| Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands AB Dequito, PGM Mol, JE van Doormaal, RJ Zaal, PMLA van den Bemt, ... Drug safety 34 (11), 1089-1100, 2011 | 104 | 2011 |
